Literature DB >> 9488267

Visual acuity and visual field impairment in Usher syndrome.

A Edwards1, G A Fishman, R J Anderson, S Grover, D J Derlacki.   

Abstract

OBJECTIVE: To determine the extent of visual acuity and visual field impairment in patients with types 1 and 2 Usher syndrome.
METHODS: The records of 53 patients with type 1 and 120 patients with type 2 Usher syndrome were reviewed for visual acuity and visual field area at their most recent visit. Visual field areas were determined by planimetry of the II4e and V4e isopters obtained with a Goldmann perimeter. Both ordinary and logistic regression models were used to evaluate differences in visual acuity and visual field impairment between patients with type 1 and type 2 Usher syndrome.
RESULTS: The difference in visual acuity of the better eye between patients with type 1 and type 2 varied by patient age (P=.01, based on a multiple regression model). The maximum difference in visual acuity between the 2 groups occurred during the third and fourth decades of life (with the type 1 patients being more impaired), while more similar acuities were seen in both younger and older patients. Fifty-one percent (n=27) of the type 1 patients had a visual acuity of 20/40 or better in at least 1 eye compared with 72% (n=87) of the type 2 patients (age-adjusted odds ratio, 3.9). Visual field area to both the II4e (P=.001) and V4e (P<.001) targets was more impaired in the better eye of type 1 patients than type 2 patients. A concentric central visual field greater than 20 degrees in at least 1 eye was present in 20 (59%) of the available 34 visual fields of type 1 patients compared with 70 (67%) of the available 104 visual fields of type 2 patients (age-adjusted odds ratio, 2.9) with the V4e target and in 6 (21%) of the available 29 visual fields of type 1 patients compared with 36 (38%) of the available 94 visual fields of type 2 patients (age-adjusted odds ratio, 4.9) with the II4e target. The fraction of patients who had a visual acuity of 20/40 or better and a concentric central visual field greater than 20 degrees to the II4e target in at least 1 eye was 17% (n=5) in the type 1 patients and 35% (n=33) in the type 2 patients (age-adjusted odds ratio, 3.9).
CONCLUSIONS: Visual acuity and visual field area were more impaired in patients with type 1 than type 2 Usher syndrome. Of note, 27 of 53 type 1 (51%) and 87 of 120 type 2 (72%) patients had a visual acuity of 20/40 or better in at least 1 eye. These data are useful for overall counseling of patients with Usher syndrome.

Entities:  

Mesh:

Year:  1998        PMID: 9488267     DOI: 10.1001/archopht.116.2.165

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  15 in total

1.  Full-field electroretinography, visual acuity and visual fields in Usher syndrome: a multicentre European study.

Authors:  Katarina Stingl; Anne Kurtenbach; Gesa Hahn; Christoph Kernstock; Stephanie Hipp; Ditta Zobor; Susanne Kohl; Crystel Bonnet; Saddek Mohand-Saïd; Isabelle Audo; Ana Fakin; Marko Hawlina; Francesco Testa; Francesca Simonelli; Christine Petit; Jose-Alain Sahel; Eberhart Zrenner
Journal:  Doc Ophthalmol       Date:  2019-07-02       Impact factor: 2.379

2.  Early diagnosis of Usher syndrome in children.

Authors:  M B Mets; N M Young; A Pass; J B Lasky
Journal:  Trans Am Ophthalmol Soc       Date:  2000

3.  Retinal disease course in Usher syndrome 1B due to MYO7A mutations.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Dan Gibbs; Alexander Sumaroka; Alejandro J Roman; Tomas S Aleman; Sharon B Schwartz; Melani B Olivares; Robert C Russell; Janet D Steinberg; Margaret A Kenna; William J Kimberling; Heidi L Rehm; David S Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-07       Impact factor: 4.799

4.  Longitudinal and cross-sectional study of patients with early-onset severe retinal dystrophy associated with RPE65 mutations.

Authors:  Karina Paunescu; Bettina Wabbels; Markus N Preising; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-24       Impact factor: 3.117

Review 5.  Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.

Authors:  Melissa K Jones; Bin Lu; Sergey Girman; Shaomei Wang
Journal:  Prog Retin Eye Res       Date:  2017-01-19       Impact factor: 21.198

6.  Novel Missense and Splice Site Mutations in USH2A, CDH23, PCDH15, and ADGRV1 Are Associated With Usher Syndrome in Lebanon.

Authors:  Lama Jaffal; Hanane Akhdar; Hawraa Joumaa; Mariam Ibrahim; Zahraa Chhouri; Alexandre Assi; Charles Helou; Hane Lee; Go Hun Seo; Wissam H Joumaa; Said El Shamieh
Journal:  Front Genet       Date:  2022-05-16       Impact factor: 4.772

7.  Is it Usher syndrome? Collaborative diagnosis and molecular genetics of patients with visual impairment and hearing loss.

Authors:  Heather A Stiff; Christina M Sloan-Heggen; Ashley Ko; Wanda L Pfeifer; Diana L Kolbe; Carla J Nishimura; Kathy L Frees; Kevin T Booth; Donghong Wang; Amy E Weaver; Hela Azaiez; John Kamholz; Richard J H Smith; Arlene V Drack
Journal:  Ophthalmic Genet       Date:  2020-04-13       Impact factor: 1.803

Review 8.  Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities.

Authors:  Pranav Mathur; Jun Yang
Journal:  Biochim Biophys Acta       Date:  2014-12-04

9.  Current understanding of usher syndrome type II.

Authors:  Jun Yang; Le Wang; Hongman Song; Maxim Sokolov
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

10.  Unravelling the pathogenic role and genotype-phenotype correlation of the USH2A p.(Cys759Phe) variant among Spanish families.

Authors:  Raquel Pérez-Carro; Fiona Blanco-Kelly; Lilián Galbis-Martínez; Gema García-García; Elena Aller; Blanca García-Sandoval; Pablo Mínguez; Marta Corton; Ignacio Mahíllo-Fernández; Inmaculada Martín-Mérida; Almudena Avila-Fernández; José M Millán; Carmen Ayuso
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.